Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Regeneration of fat cells from myofibroblasts during wound healing
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Biotin
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Evaluation of Serum Toll-Like Receptor 4, Interferon Gamma, and Interleukin-17 Levels in Iraqi Patients with Alopecia Areata
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket Immunosuppressives
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- 0034 Cross-species insights into hair follicle-T cell interactions in discoid lupus erythematosus: A comparison of human, canine and mouse models using spatial transcriptomics
- SnapshotDx Quiz: December 2018
- Frontal Fibrosing Alopecia During Treatment of Chronic Hepatitis C: A Case Report
- Dermatologic therapy: December 1986 to December 1987
- 1327 Effect of ginsenoside Rd on dermal epidermal junction in fibroblast
- 478 Mutation-specific siRNA Knockdown of GJB2 − Potential gene therapy for Keratitis-ichthyosis-deafness Syndrome
- Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
- Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes
- Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes